According to the research report titled ‘North America Sleep Apnea Therapeutics and Diagnostics Market 2021-2028’, available with Market Study Report, North America sleep apnea therapeutics and diagnostics market is expected to register 6.22% CAGR over 2021-2028.
 

Growing prevalence of sleep apnea, growing awareness related to the negative impact of this condition if left untreated, and subsequent increase in the demand for positive airway pressure (PAP) devices are catalyzing the growth of North America sleep apnea therapeutics and diagnostics market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4069454/
 

Disturbance of sleep-cycle due to soaring use of gadgets at night, increasing adoption of at-home monitoring devices, and surging cases of obesity are further enhancing the market growth. Moreover, rising geriatric populace and technological advancements are also fueling the industry expansion.
 

Elaborating on the negatives, high cost of sleep apnea devices, and their partial reimbursement scenario, along with dearth of patience adherence to the treatment recommended by healthcare professionals are likely to hamper the industry development over the analysis timeframe. Debilitating impact of Covid-19 pandemic on the clinical diagnosis of sleep apnea due to lockdowns and inadequate funding for research are also limiting the industry expansion.
 

With respect to product type, North America sleep apnea therapeutics and diagnostics marketplace is bifurcated into therapeutics and diagnostics & monitoring. Moving on to end-user terrain, the industry space is fragmented into home care settings and hospitals & sleep laboratories.
 

As per the regional analysis, Canada market is slated to records substantial gains in the upcoming years due to increased pervasiveness of sleep apnea. In fact, a July 2019 publication by Lancet cites that the estimated prevalence rate of obstructive sleep apnea in adults aged 30-69 years is 4.8% in Canadians.
 

Speaking of the competitive landscape, Fisher & Paykel Healthcare Corporation Ltd., BMC Medical Co., Ltd., Cadwell Industries Inc., Invacare Corporation, Koninklijke Philips N.V., Nihon Kohden Corporation, ResMed Inc., Somnomedics GmbH, GE Healthcare, Teleflex Inc., DeVilbiss Healthcare LLC, Signifier Medical Technologies Ltd., Itamar Medical Ltd., Vyaire Medical Inc., Braebon Medical Corporation, Medtronic plc and Smiths Medical Inc. are the prominent players in North America sleep apnea therapeutics and diagnostics market